NCT05818683 2026-02-13
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Prostate Cancer
Janssen Research & Development, LLC
Phase 1 Recruiting
Clinical Trials
1 trialsInterventional × Metastatic Castration-resistant Prostate Neoplasms × Abiraterone Acetate × Clear all